Nos publications

Streamlining the design of sustained release matrix tablets using mathematical modeling for drug release optimization

  • Poster

CRS Annual Meeting – Chicago (USA)  - jui 2014

Y. Rosiaux, F. Desvignes, JM. Girard, C. Miolane, S. Hughes and D. Marchaud

Smart strategies for sustained release matrix tablets: Compritol® 888 ATO

  • Whitepaper

OutsourcingPharma - mai 2014

Gattefossé

This white paper gives an overview of how Compritol® 888 ATO provides clinically relevant sustained drug release profiles along with biopharmaceutical, formulation and manufacturing advantages.

Sustained release levadopa mini-tablets containing Compritol® 888: a viable approach for special patient populations

  • Poster

AAPS Annual Meeting and Exposition – San Antonio (USA)  - nov 2013

M. MESSINA, M. ROBERTS, S. MOSTAFA, Y. CUPPOK

Télécharger (.pdf - 570 Ko)

Percolation threshold of Compritol® 888 in matrix tablets: assessing the minimum concentration to create an infinite lipid network

  • Poster

AAPS Annual Meeting and Exposition – San Antonio (USA)  - nov 2013

Y. CUPPOK-ROSIAUX, J-M. GIRARD, F. DESVIGNES, C. MIOLANE, D. MARCHAUD

Télécharger (.pdf - 922.9 Ko)

Compritol®888 ATO a lipid excipient for sustained release of highly water soluble active: formulation, scale-up and IVIVC study.

  • Scientific publication

Curr Drug Deliv. 2013 Oct;10(5):548-56. - oct 2013

Patere SN, Desai NS, Jain AS, Kadam PP, Thatte UM, Gogtay N, Kapadia CJ, Farah N, Nagarsenker MS.

Synergic effect of two glycerides to increase stability and ethanol resistance of sustained release matrix tablets

  • Poster

AAPS Annual Meeting & Exposition – Chicago (USA)  - oct 2012

Yvonne CUPPOK, Jean-Michel GIRARD, Cédric MIOLANE, Delphine MARCHAUD

Télécharger (.pdf - 600.32 Ko)

Compritol® 888 ATO lipid matrices for sustained release processed by hot melt extrusion

  • Poster

CRS Annual Meeting – Québec (Canada)  - jui 2012

Mohammed MANIRUZZAMAN, Kapilkumar VITHANI, Cédric MIOLANE, Shabbir MOSTAFA, Yvonne CUPPOK, Dennis DOUROUMIS

Télécharger (.pdf - 0 octet)

Formulation Effects on Drug Release from Sustained-Release Compritol® 888 ATO Tablets and Mini-Tablets

  • Poster

CRS Annual Meeting – National Harbor (USA)  - jui 2011

D. Vellucci, M. Roberts, S. Mostafa, C. Miolane, D. Marchaud

Télécharger (.pdf - 3.21 Mo)

Performance of a Compritol® 888 ATO lipid matrix tablet to deliver sustained release of diclofenac sodium

  • Poster

CRS Annual Meeting – National Harbor (USA)  - jui 2011

D. Marchaud*, E. Dauphin-Chanard, JM. Girad, C. Miolane

Télécharger (.pdf - 3.21 Mo)